Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: Add new tag
Roche Unsweetens Genentech Pot and Takes it to the Shareholders
Image by Getty Images via Daylife
Roche wants Genentech and it’s sick of waiting for a deal.
Six months after a special committee for the biotech firm’s board of directors rejected Roche’s offer of $43.7 billion or $89 a share, Roche has switched gears and dropped the offer to $86.50 per share and is taking negotiations to [...]
Posted in Deals Also tagged Deal, Genentech, Hoffmann–La Roche, Negotiate, Nutley New Jersey 1 Comment

Is a Swine Flu Vaccine Backlash on the Cards?